Retatrutide is a triple-receptor agonist targeting GLP-1, GIP, and glucagon pathways simultaneously, producing an average of 24.2% body weight reduction in Phase 2 clinical trials at the 12mg dose
Add them to yogurt for a sweet, fiber-packed snack
The retatrutide dosage chart recommends gradual titration starting at 1mg weekly, progressing through 2mg, 4mg, 8mg, and potentially 12mg based on tolerance and response
As you progress and feel more energetic, gradually increase intensity and duration
Tirzepatide drops represent another delivery approach, and the comparison between tirzepatide tablets versus injections addresses how formulation affects onset and efficacy
Thomson RL, Buckley JD, Noakes M, Clifton PM, Norman RJ, Brinkworth GD (2008) The effect of a hypocaloric diet with and without exercise training on body composition, cardiometabolic risk profile, and reproductive function in overweight and obese women with polycystic ovary syndrome